Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL
Development of a rapid and fully automated factor VIII inhibitor…
Ler MaisDevelopment of a rapid and fully automated factor VIII inhibitor…
Ler Mais